IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy
Crossref DOI link: https://doi.org/10.1007/s13300-015-0142-y
Published Online: 2015-11-18
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Freemantle, Nick
Mamdani, Muhammad
Vilsbøll, Tina
Kongsø, Jens Harald
Kvist, Kajsa
Bain, Stephen C.
Funding for this research was provided by:
Novo Nordisk A/S
Text and Data Mining valid from 2015-11-18
Article History
Received: 4 September 2015
First Online: 18 November 2015